Notification Major Share Interests

Cambridge, UK - 20th February 2019

Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs, announces: TR-1: Standard form for notification of major holdings

Download News

Back to all News